Cypress Capital Group Edwards Lifesciences Corp Transaction History

Cypress Capital Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	SELL	$83.84 - $104.76 $296,458 - $370,431	-3,536 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$78.68 - $90.67 $15,972 - $18,406	-203 Reduced 5.43%	3,536 $296,000
Q4 2020 Jan 12, 2021	SELL	$71.69 - $91.23 $26,596 - $33,846	-371 Reduced 9.03%	3,739 $341,000
Q3 2020 Oct 08, 2020	SELL	$67.19 - $87.44 $29,832 - $38,823	-444 Reduced 9.75%	4,110 $328,000
Q2 2020 Jul 10, 2020	BUY	$57.54 - $76.95 $262,037 - $350,430	4,554 New	4,554 $315,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.